OTRIVIN Paed Nasal Metered- Dose Spray

Go To

Otrivin Paed Nasal Metered-Dose Spray

Helps relieve nasal congestion in children quickly1,2

OTRIVIN Paed Nasal Metered- Dose Spray is shown to provide quick and effective relief from nasal congestion in children.

With a formulation designed for ages 1 year and older, Otrivin Paed Nasal Metered-Dose Spray demonstrates effective relief of congestion from colds and allergic rhinitis in as little as 2 minutes.2

The decongestive effects of the nasal spray may last up to 12 hours with a single application,2 resulting in:

  • Improved nasal airflow2,3
  • increased drainage of nasal secretions2
Glass nose

Direct and immediate action where it’s needed2,3

OTRIVIN Paed Nasal Metered-Dose Spray is formulated as a nasal spray to bring targeted relief from nasal decongestion. The active ingredient of xylometazoline acts locally on the nasal mucosa2,3 to effect vasoconstriction where it counts, resulting in rapid and long-lasting relief.2

Child and mother outside

OTRIVIN Paed Nasal Metered-Dose Spray is specially formulated with xylometazoline for kids: well tolerated and highly effective2

Read more

Recommend Otrivin Paed Nasal Metered-Dose Spray to your paediatric patients for well tolerated, effective relief from nasal congestion

Otrivin Paed Nasal Metered-Dose Spray

OTRIVIN Paed Nasal Metered-Dose Spray (1 ml contains 0,5 mg of xylometazoline hydrochloride)4

For parents who are looking for a fast-acting, long-lasting nasal decongestant to help their child breathe more easily.

OTRIVIN Paed Nasal Metered-Dose Spray product details

  • OTRIVIN PAED Nasal Metered-Dose Spray:

    1 ml contains 0,5 mg of xylometazoline hydrochloride4.

    Preservative: 0,011 % m/v benzalkonium Chloride4.

    Excipients: disodium edetate, disodium phosphate dodecahydrate, methylhydroxypropyl-cellulose, purified water, sodium chloride, sodium dihydrogen phosphate dihydrate, sorbitol 70 % (non-crystallising)4.

  • OTRIVIN PAED Nasal Metered-Dose Spray (0,5 mg/ml) are for nasal administration only, for children aged 2 up to 12 years of age: 1 to 2 drops of the 0, 5 mg/ml solution or one puff of the metered-dose spray into each nostril, once or twice daily, are generally sufficient; a total of 2 applications a day should not be exceeded4

    OTRIVIN should be used after blowing the nose4

    Use of OTRIVIN PAED Nasal Metered-Dose Spray4:

    Before the first application, prime the pump by actuating 4 times. Once primed, the pump will normally remain charged throughout regular daily treatment periods. If the spray is not ejected during the full actuation stroke, or if the product has not been used for longer than 7 days, the pump for the OTRIVIN PAED Nasal Metered-Dose Spray will need to be reprimed with 2 actuations and the pump for the OTRIVIN PAED Nasal Metered-Dose Spray will need to be reprimed with 4 actuations. Insert the nozzle into the nostril and press once firmly on the spray head and breathe in at the same time. Then withdraw the nozzle before releasing pressure. Repeat the operation in the other nostril. Clean and replace the protective cap4.

    NOTE: In children aged 2 up to 12 years of age, only OTRIVIN PAED Nasal Metered-Dose Spray of 0, 5 mg/ml should be employed4.

    ALWAYS READ THE LABEL BEFORE USE.

  • WARNINGS AND SPECIAL PRECAUTIONS:

    OTRIVIN should be used with caution in patients showing a strong reaction to sympathomimetic agents, as evidenced by signs of insomnia, dizziness as manifested by signs of insomnia, dizziness, tremor, cardiac dysrhythmias or elevated blood pressure.

    OTRIVIN should be used with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, epistaxis, phaechromocytoma, prostatic hypertrophy, monoamine oxidase inhibitors (MAOI) treatment or who have received them in the last two weeks (see INTERACTIONS).

    Do not exceed the recommended dose, especially in children and in the elderly.

    OTRIVIN should not be used for more than ten consecutive days: prolonged or excessive use may cause rebound congestion and/or atrophy of the nasal mucosa.

    INTERACTIONS:

    The concomitant use of OTRIVIN with monoamine oxidase (MAO) inhibitors or tricyclic or tetracyclic antidepressants may cause an increase in blood pressure due to cardiovascular effects of these substances (see WARNINGS AND SPECIAL PRECAUTIONS).

Otrivin – your Nasal Health Partner

Otrivin logo

The Otrivin range

Find out how the Otrivin range can help your patients.

Find out more

Register Now

Register Now

Join the Community

Register now

Patient care resources icon

Patient care resources

Download resources for your patients.

Find out more